Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: DRUG: Dexamethasone|OTHER: Laboratory Biomarker Analysis|DRUG: Netupitant/Palonosetron Hydrochloride|DRUG: Olanzapine|OTHER: Placebo|DRUG: Prochlorperazine|OTHER: Quality-of-Life Assessment
Sponsor: University of Rochester NCORP Research Base
Collaborators: National Cancer Institute (NCI)